Clinical Trial Update: Relative Bioavailability Study in Healthy Subjects [Phase 1]

View source ↗

Summary

This release documents a Phase 1 relative bioavailability study in healthy subjects for a GlaxoSmithKline compound being developed for bacterial infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED